Scribe Therapeutics Inc. is a clinical-stage biotechnology company. The Company develops CRISPR-based genetic medicines for the treatment of cardiovascular and metabolic diseases. Scribe Therapeutics operates in the United States.
more
Refresh
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.